| Lastest Insider Transactions Of JOHNSON & JOHNSON ( JNJ ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2026-06-11 | Sell | 10,000 | 241.15 | 2,411,500 | 2026-06-12 17:23:31 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2026-06-11 | Option Exercise | 10,000 | 115.67 | 1,156,700 | 2026-06-12 17:23:31 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2026-05-01 | Option Exercise | 25,255 | 0.00 | 0 | 2026-05-04 16:58:59 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2026-02-20 | Sell | 1,322 | 245.66 | 324,763 | 2026-02-23 17:20:21 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2026-02-13 | Sell | 62,080 | 243.39 | 15,109,759 | 2026-02-18 21:12:32 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2026-02-13 | Option Exercise | 73,140 | 139.50 | 10,202,710 | 2026-02-18 21:12:32 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2026-02-13 | Sell | 62,080 | 243.39 | 15,109,759 | 2026-02-18 21:12:32 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2026-02-13 | Option Exercise | 73,140 | 139.50 | 10,202,710 | 2026-02-18 21:12:32 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2026-02-13 | Option Exercise | 15,598 | 0.00 | 0 | 2026-02-18 21:12:26 |
| JNJ | JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | 2026-02-13 | Option Exercise | 5,006 | 0.00 | 0 | 2026-02-18 21:12:20 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2026-02-13 | Sell | 89,654 | 242.80 | 21,767,826 | 2026-02-18 21:12:14 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2026-02-13 | Option Exercise | 107,784 | 76.02 | 8,193,223 | 2026-02-18 21:12:14 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2026-02-13 | Option Exercise | 3,736 | 0.00 | 0 | 2026-02-18 21:12:08 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2026-02-15 | Sell | 53,931 | 243.00 | 13,105,233 | 2026-02-18 21:12:02 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2026-02-15 | Option Exercise | 54,844 | 147.75 | 8,103,282 | 2026-02-18 21:12:02 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | 2026-02-13 | Option Exercise | 16,381 | 0.00 | 0 | 2026-02-18 21:11:55 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2026-02-13 | Option Exercise | 32,155 | 0.00 | 0 | 2026-02-18 21:11:49 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2026-02-13 | Sell | 22,623 | 244.33 | 5,527,506 | 2026-02-18 21:11:43 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2026-02-13 | Option Exercise | 29,554 | 92.76 | 2,741,335 | 2026-02-18 21:11:43 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2026-02-13 | Option Exercise | 84,710 | 0.00 | 0 | 2026-02-18 21:11:37 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2026-02-13 | Sell | 6,197 | 243.39 | 1,508,288 | 2026-02-18 21:11:31 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2026-02-13 | Option Exercise | 10,020 | 0.00 | 0 | 2026-02-18 21:11:31 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2026-02-06 | Option Exercise | 15,571 | 101.87 | 1,586,218 | 2026-02-10 21:46:41 |
| JNJ | JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | 2026-02-06 | Option Exercise | 5,625 | 101.87 | 573,019 | 2026-02-09 19:42:46 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2026-02-06 | Option Exercise | 38,945 | 101.87 | 3,967,327 | 2026-02-09 19:40:10 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | EVP, Chief Legal Officer | 2026-02-05 | Option Exercise | 8,921 | 129.51 | 1,155,359 | 2026-02-06 17:46:50 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2026-01-26 | Sell | 100,000 | 221.23 | 22,122,894 | 2026-01-28 18:07:44 |
| JNJ | JOHNSON & JOHNSON | MORIKIS JOHN G | Directior | 2025-11-26 | Buy | 1,250 | 206.15 | 257,688 | 2025-12-01 16:15:39 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2025-10-17 | Sell | 21,721 | 192.71 | 4,185,793 | 2025-10-20 19:13:56 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2025-10-17 | Option Exercise | 21,721 | 157.92 | 3,430,180 | 2025-10-20 19:13:56 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2025-09-04 | Sell | 56,471 | 177.81 | 10,040,883 | 2025-09-05 18:00:47 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2025-09-04 | Option Exercise | 56,471 | 101.87 | 5,752,701 | 2025-09-05 18:00:47 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2025-08-29 | Option Exercise | 11,521 | 115.67 | 1,332,634 | 2025-09-03 17:13:57 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2025-08-22 | Sell | 125,824 | 179.21 | 22,548,654 | 2025-08-25 19:12:16 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2025-08-22 | Option Exercise | 125,824 | 101.87 | 12,817,691 | 2025-08-25 19:12:16 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-08-15 | Sell | 16,820 | 176.91 | 2,975,571 | 2025-08-18 18:19:14 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-08-15 | Option Exercise | 16,820 | 101.87 | 1,713,453 | 2025-08-18 18:19:14 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-08-15 | Sell | 16,820 | 176.91 | 2,975,571 | 2025-08-18 18:19:14 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-08-15 | Option Exercise | 16,820 | 101.87 | 1,713,453 | 2025-08-18 18:19:14 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2025-07-17 | Sell | 19,137 | 163.55 | 3,129,830 | 2025-07-18 16:12:41 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2025-05-01 | Option Exercise | 25,255 | 0.00 | 0 | 2025-05-05 17:10:14 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2025-02-25 | Sell | 6,999 | 165.88 | 1,160,994 | 2025-02-26 18:42:45 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2025-02-25 | Option Exercise | 6,999 | 101.87 | 712,988 | 2025-02-26 18:42:45 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2025-02-14 | Option Exercise | 2,806 | 0.00 | 0 | 2025-02-18 21:46:21 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2025-02-13 | Sell | 403 | 156.15 | 62,928 | 2025-02-18 21:33:38 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2025-02-13 | Option Exercise | 3,293 | 0.00 | 0 | 2025-02-18 21:33:38 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2025-02-13 | Option Exercise | 8,625 | 0.00 | 0 | 2025-02-18 21:16:54 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-02-13 | Option Exercise | 23,080 | 0.00 | 0 | 2025-02-18 21:13:06 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2025-02-15 | Option Exercise | 1,350 | 0.00 | 0 | 2025-02-18 21:11:45 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2025-02-13 | Option Exercise | 22,414 | 0.00 | 0 | 2025-02-18 21:08:02 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2025-02-13 | Option Exercise | 6,018 | 0.00 | 0 | 2025-02-18 21:06:32 |
| JNJ | JOHNSON & JOHNSON | Mulholland Kristen | EVP, Chief HR Officer | 2025-02-13 | Option Exercise | 3,438 | 0.00 | 0 | 2025-02-18 21:05:11 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2025-02-13 | Option Exercise | 3,815 | 0.00 | 0 | 2025-02-18 21:03:37 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2025-02-13 | Option Exercise | 31,487 | 0.00 | 0 | 2025-02-18 21:02:35 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2025-02-13 | Option Exercise | 2,852 | 0.00 | 0 | 2025-02-18 21:01:05 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2025-02-13 | Option Exercise | 5,640 | 0.00 | 0 | 2025-02-18 20:58:25 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2025-02-07 | Option Exercise | 126,369 | 100.06 | 12,644,482 | 2025-02-11 19:43:12 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2025-02-07 | Option Exercise | 32,762 | 100.06 | 3,278,166 | 2025-02-11 19:42:18 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2025-02-07 | Option Exercise | 58,504 | 100.06 | 5,853,910 | 2025-02-11 19:41:17 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-02-07 | Sell | 13,015 | 153.89 | 2,002,878 | 2025-02-11 19:40:16 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-02-07 | Option Exercise | 13,015 | 100.06 | 1,302,281 | 2025-02-11 19:40:16 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-02-07 | Sell | 13,015 | 153.89 | 2,002,878 | 2025-02-11 19:40:16 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2025-02-07 | Option Exercise | 13,015 | 100.06 | 1,302,281 | 2025-02-11 19:40:16 |
| JNJ | JOHNSON & JOHNSON | WEINBERGER MARK A | Directior | 2024-12-12 | Buy | 1,000 | 147.22 | 147,220 | 2024-12-12 17:27:36 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2024-05-01 | Option Exercise | 25,255 | 0.00 | 0 | 2024-10-31 17:57:46 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-07-08 | Option Exercise | 9,809 | 0.00 | 0 | 2024-07-09 17:48:38 |
| JNJ | JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | 2024-05-01 | Option Exercise | 22,255 | 0.00 | 0 | 2024-05-03 16:31:19 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-03-13 | Sell | 8,891 | 162.16 | 1,441,765 | 2024-03-13 16:36:32 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2024-02-13 | Option Exercise | 651 | 0.00 | 0 | 2024-02-15 16:53:53 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2024-02-13 | Option Exercise | 1,780 | 0.00 | 0 | 2024-02-15 16:53:51 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2024-02-13 | Option Exercise | 1,302 | 0.00 | 0 | 2024-02-15 16:53:44 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2024-02-13 | Option Exercise | 447 | 0.00 | 0 | 2024-02-15 16:53:40 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2024-02-13 | Option Exercise | 499 | 0.00 | 0 | 2024-02-15 16:53:35 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2024-02-13 | Option Exercise | 925 | 0.00 | 0 | 2024-02-15 16:53:34 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2024-02-13 | Option Exercise | 834 | 0.00 | 0 | 2024-02-15 16:53:33 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-13 | Option Exercise | 3,470 | 0.00 | 0 | 2024-02-15 16:53:32 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-02-13 | Option Exercise | 408 | 0.00 | 0 | 2024-02-15 16:53:23 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2024-02-13 | Option Exercise | 651 | 0.00 | 0 | 2024-02-15 16:53:23 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2024-02-13 | Option Exercise | 313 | 0.00 | 0 | 2024-02-15 16:53:07 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-02-12 | Option Exercise | 4,701 | 0.00 | 0 | 2024-02-14 18:36:50 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2024-02-12 | Option Exercise | 8,932 | 0.00 | 0 | 2024-02-14 18:36:47 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2024-02-12 | Option Exercise | 25,835 | 0.00 | 0 | 2024-02-14 18:36:45 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2024-02-12 | Option Exercise | 2,859 | 0.00 | 0 | 2024-02-14 18:36:41 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WWC. Innovative Medicine | 2024-02-12 | Option Exercise | 26,202 | 0.00 | 0 | 2024-02-14 18:36:31 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2024-02-12 | Option Exercise | 14,960 | 0.00 | 0 | 2024-02-14 18:36:25 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | EVP, CIO | 2024-02-12 | Option Exercise | 5,456 | 0.00 | 0 | 2024-02-14 18:36:22 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-12 | Option Exercise | 36,618 | 0.00 | 0 | 2024-02-14 18:36:19 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2024-02-12 | Option Exercise | 5,736 | 0.00 | 0 | 2024-02-14 18:36:17 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2024-02-12 | Option Exercise | 1,912 | 0.00 | 0 | 2024-02-14 18:36:13 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2024-02-12 | Option Exercise | 13,813 | 0.00 | 0 | 2024-02-14 18:36:08 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-09 | Option Exercise | 130,969 | 90.44 | 11,844,836 | 2024-02-13 17:18:25 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 2024-02-08 | Sell | 59,397 | 156.27 | 9,281,969 | 2024-02-12 19:25:22 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 2024-02-08 | Option Exercise | 63,136 | 85.08 | 5,371,865 | 2024-02-12 19:25:22 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2024-02-08 | Option Exercise | 5,225 | 0.00 | 0 | 2024-02-12 19:25:15 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2024-02-08 | Option Exercise | 1,971 | 0.00 | 0 | 2024-02-12 19:25:14 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2024-02-08 | Option Exercise | 3,686 | 0.00 | 0 | 2024-02-12 19:25:10 |
| JNJ | JOHNSON & JOHNSON | Forminard Elizabeth | Executive VP, General Counsel | 2024-02-08 | Option Exercise | 979 | 0.00 | 0 | 2024-02-12 19:24:59 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2024-02-08 | Option Exercise | 1,868 | 0.00 | 0 | 2024-02-12 19:24:57 |
| JNJ | JOHNSON & JOHNSON | Schmid Timothy | EVP, WW Chair, MedTech | 2024-02-08 | Option Exercise | 1,964 | 0.00 | 0 | 2024-02-12 19:24:45 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2024-02-08 | Option Exercise | 2,135 | 0.00 | 0 | 2024-02-12 19:24:38 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2024-02-08 | Option Exercise | 3,059 | 0.00 | 0 | 2024-02-12 19:24:31 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2024-02-08 | Option Exercise | 1,880 | 0.00 | 0 | 2024-02-12 19:24:24 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2024-02-08 | Option Exercise | 655 | 0.00 | 0 | 2024-02-12 19:24:16 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2023-07-25 | Sell | 20,000 | 170.32 | 3,406,498 | 2023-07-27 17:52:58 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2023-07-26 | Sell | 14,698 | 172.00 | 2,528,056 | 2023-07-27 17:52:57 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2023-07-26 | Option Exercise | 14,698 | 90.44 | 1,329,287 | 2023-07-27 17:52:57 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2023-06-12 | Sell | 12,465 | 160.00 | 1,994,400 | 2023-06-14 16:19:45 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2023-03-06 | Sell | 1,061 | 154.76 | 164,199 | 2023-03-08 16:16:29 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2023-02-10 | Option Exercise | 5,220 | 0.00 | 0 | 2023-02-14 16:37:16 |
| JNJ | JOHNSON & JOHNSON | Wengel Kathryn E | EVP, Chief TO and Risk Officer | 2023-02-10 | Option Exercise | 1,807 | 0.00 | 0 | 2023-02-14 16:37:04 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2023-02-10 | Option Exercise | 3,449 | 0.00 | 0 | 2023-02-14 16:36:25 |
| JNJ | JOHNSON & JOHNSON | Taubert Jennifer L | EVP, WW Chair, Pharmaceuticals | 2023-02-10 | Option Exercise | 3,570 | 0.00 | 0 | 2023-02-14 16:36:18 |
| JNJ | JOHNSON & JOHNSON | McEvoy Ashley | EVP, WW Chair, MedTech | 2023-02-10 | Option Exercise | 2,999 | 0.00 | 0 | 2023-02-14 16:36:06 |
| JNJ | JOHNSON & JOHNSON | Hait William | See Remarks | 2023-02-10 | Option Exercise | 3,856 | 0.00 | 0 | 2023-02-14 16:35:39 |
| JNJ | JOHNSON & JOHNSON | Mongon Thibaut | Exec VP, WW Chair, Cons Health | 2023-02-10 | Option Exercise | 2,285 | 0.00 | 0 | 2023-02-14 16:35:37 |
| JNJ | JOHNSON & JOHNSON | Decker Robert J | VP Corporate Controller | 2023-02-10 | Option Exercise | 581 | 0.00 | 0 | 2023-02-14 16:35:30 |
| JNJ | JOHNSON & JOHNSON | Broadhurst Vanessa | EVP, Global Corp Affairs | 2023-02-10 | Option Exercise | 1,592 | 0.00 | 0 | 2023-02-14 16:35:07 |
| JNJ | JOHNSON & JOHNSON | Fasolo Peter | Exec VP, Chief HR Officer | 2023-02-10 | Option Exercise | 2,078 | 0.00 | 0 | 2023-02-14 16:35:02 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2022-02-14 | Option Exercise | 1,291 | 0.00 | 0 | 2023-02-14 16:34:39 |
| JNJ | JOHNSON & JOHNSON | Swanson James D. | See Remarks | 2022-02-14 | Option Exercise | 1,291 | 0.00 | 0 | 2023-02-14 16:34:39 |
| JNJ | JOHNSON & JOHNSON | Gorsky Alex | Directior | 2023-01-17 | Option Exercise | 547,692 | 72.54 | 39,729,576 | 2023-01-18 16:39:45 |
| JNJ | JOHNSON & JOHNSON | Duato Joaquin | CEO and Chairman of the Board | 2023-01-17 | Option Exercise | 148,538 | 72.54 | 10,774,947 | 2023-01-18 16:39:41 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2022-12-13 | Sell | 14,781 | 179.60 | 2,654,661 | 2022-12-15 16:34:45 |
| JNJ | JOHNSON & JOHNSON | Wolk Joseph J | Exec VP, CFO | 2022-12-13 | Option Exercise | 14,781 | 88.19 | 1,303,589 | 2022-12-15 16:34:45 |
